Vitamin B6 ( DrugBank: Vitamin B6 )

2 diseases

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	2
206	Fragile X syndrome	1

6. Parkinson disease

Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01238926 (ClinicalTrials.gov)	May 2008	9/11/2010	Vitamin B6, B12, Folic Acid and Exercise in Parkinson's Disease	Effects of Vitamin Supplementation and Strength Training in Parkinson's Disease	Parkinson's Disease	Dietary Supplement: PD vitamin supplementation;Other: PD exercise intervention;Other: PD vitamin + exercise	New York Institute of Technology	Stony Brook University	Active, not recruiting	50 Years	80 Years	Both	40	N/A	United States
2	NCT00853879 (ClinicalTrials.gov)	December 2006	26/2/2009	An Exploratory, Randomized, Blinded, Placebo-Controlled Trial of Folic Acid and L-methylfolate in Parkinson's Disease	An Exploratory, Randomized, Blinded, Placebo-Controlled Trial of Folic Acid and L-methylfolate in Parkinson's Disease	Parkinson's Disease	Dietary Supplement: Folic Acid, Vitamin B6, Vitamin B12;Dietary Supplement: B6, B12, L-methylfolate;Dietary Supplement: B6, B12, Placebo	North Shore Long Island Jewish Health System	NULL	Terminated	30 Years	N/A	Both	150	N/A	United States

Clinical trials : 108 / Drugs : 91 - (DrugBank : 36) / Drug target genes : 52 - Drug target pathways : 77

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05030129 (ClinicalTrials.gov)	October 7, 2021	5/8/2021	Single Blind Study of Ergoloid Mesylates, 5-HTP and the Combination in Adult Males With Fragile X Syndrome	An Exploratory Single Blind Study of Ergoloid Mesylates, 5-Hydroxytryptophan, and the Combination in Adult Males With Fragile X Syndrome	Fragile X Syndrome	Dietary Supplement: 5-Hydroxytryptophan / Vitamin B6;Drug: Ergoloid Mesylate;Other: Placebo	Elizabeth Berry-Kravis	NULL	Recruiting	18 Years	45 Years	Male	15	Phase 2	United States